Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer biotech ...
This project is an open source "lite" version of an arcade encoder I sell in my shop. If you want to support my work I sell the fully featured ones at https://daemonbite.com. The input lag for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results